Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 43 entries
Sorted by: Best Match Show Resources per page
[Replacement of an intervertebral disc, using a ceramic prosthesis, in the treatment of degenerative diseases of the spine.].

Acta chirurgiae orthopaedicae et traumatologiae Cechoslovaca

Filip M, Veselský P, Strnad Z, Laník P.
PMID: 20470508
Acta Chir Orthop Traumatol Cech. 1995;62(4):226-31.

The authors tested in experimentally a suitable shape and approach to replacement of an intervertebral disc by means of an endoprosthesis made from glass-ceramic material of Lasak Co. In experiments on post-mortem material they succeded eventually in creating the...

Cite
Filip M, Veselský P, Strnad Z, et al. Náhrada meziobratlové ploténky pomocí keramické protézy pri lécbe degenerativních onemocnení pátere. [Replacement of an intervertebral disc, using a ceramic prosthesis, in the treatment of degenerative diseases of the spine.]. Acta Chir Orthop Traumatol Cech. 1995;62(4):226-31
Filip, M., Veselský, P., Strnad, Z., & Laník, P. (1995). Náhrada meziobratlové ploténky pomocí keramické protézy pri lécbe degenerativních onemocnení pátere. [Replacement of an intervertebral disc, using a ceramic prosthesis, in the treatment of degenerative diseases of the spine.]. Acta chirurgiae orthopaedicae et traumatologiae Cechoslovaca, 62(4), 226-31.
Filip, M, et al. "Náhrada meziobratlové ploténky pomocí keramické protézy pri lécbe degenerativních onemocnení pátere." [Replacement of an intervertebral disc, using a ceramic prosthesis, in the treatment of degenerative diseases of the spine.]. Acta chirurgiae orthopaedicae et traumatologiae Cechoslovaca vol. 62,4 (1995): 226-31.
Filip M, Veselský P, Strnad Z, Laník P. Náhrada meziobratlové ploténky pomocí keramické protézy pri lécbe degenerativních onemocnení pátere. [Replacement of an intervertebral disc, using a ceramic prosthesis, in the treatment of degenerative diseases of the spine.]. Acta Chir Orthop Traumatol Cech. 1995;62(4):226-31. Czech. PMID: 20470508.
Copy Download .nbib Format: NLM
Hypertext atlas of fetal and neonatal pathology.

Diagnostic pathology

Jezová M, Múcková K, Soucek O, Feit J, Vlasín P.
PMID: 18673523
Diagn Pathol. 2008 Jul 15;3:S9. doi: 10.1186/1746-1596-3-S1-S9.

Hypertext atlas of fetal and neonatal pathology is a free resource for pregraduate students of medicine, pathologists and other health professionals dealing with prenatal medicine. The atlas can be found at http://www.muni.cz/atlases. The access is restricted to registered users....

Cite
Jezová M, Múcková K, Soucek O, et al. Hypertext atlas of fetal and neonatal pathology. Diagn Pathol. 2008;3:S9doi: 10.1186/1746-1596-3-S1-S9.
Jezová, M., Múcková, K., Soucek, O., Feit, J., & Vlasín, P. (2008). Hypertext atlas of fetal and neonatal pathology. Diagnostic pathology, 3S9. https://doi.org/10.1186/1746-1596-3-S1-S9
Jezová, Marta, et al. "Hypertext atlas of fetal and neonatal pathology." Diagnostic pathology vol. 3 (2008): S9. doi: https://doi.org/10.1186/1746-1596-3-S1-S9
Jezová M, Múcková K, Soucek O, Feit J, Vlasín P. Hypertext atlas of fetal and neonatal pathology. Diagn Pathol. 2008 Jul 15;3:S9. doi: 10.1186/1746-1596-3-S1-S9. PMID: 18673523; PMCID: PMC2500115.
Copy Download .nbib Format: NLM
Nitric Oxide Synthase Dependency in Hydroxyurea Inhibition of Erythroid Progenitor Growth.

Genes

Subotički T, Ajtić OM, Đikić D, Santibanez JF, Tošić M, Čokić VP.
PMID: 34440315
Genes (Basel). 2021 Jul 27;12(8). doi: 10.3390/genes12081145.

Hydroxyurea (HU) causes nitric oxide (NO) bioactivation, acting as both a NO donor and a stimulator of NO synthase (NOS). To examine whether HU effects are NO mediated by chemical degradation or enzymatic induction, we studied human and mouse...

Cite
Subotički T, Ajtić OM, Đikić D, et al. Nitric Oxide Synthase Dependency in Hydroxyurea Inhibition of Erythroid Progenitor Growth. Genes (Basel). 2021;12(8)doi: 10.3390/genes12081145.
Subotički, T., Ajtić, O. M., Đikić, D., Santibanez, J. F., Tošić, M., & Čokić, V. P. (2021). Nitric Oxide Synthase Dependency in Hydroxyurea Inhibition of Erythroid Progenitor Growth. Genes, 12(8), . https://doi.org/10.3390/genes12081145
Subotički, Tijana, et al. "Nitric Oxide Synthase Dependency in Hydroxyurea Inhibition of Erythroid Progenitor Growth." Genes vol. 12,8 (2021). doi: https://doi.org/10.3390/genes12081145
Subotički T, Ajtić OM, Đikić D, Santibanez JF, Tošić M, Čokić VP. Nitric Oxide Synthase Dependency in Hydroxyurea Inhibition of Erythroid Progenitor Growth. Genes (Basel). 2021 Jul 27;12(8). doi: 10.3390/genes12081145. PMID: 34440315; PMCID: PMC8391407.
Copy Download .nbib Format: NLM
Hydrogen bonding and molecular orientation at the liquid-vapour interface of water.

Physical chemistry chemical physics : PCCP

Cipcigan FS, Sokhan VP, Jones AP, Crain J, Martyna GJ.
PMID: 25715668
Phys Chem Chem Phys. 2015 Apr 14;17(14):8660-9. doi: 10.1039/c4cp05506c. Epub 2015 Feb 26.

We determine the molecular structure and orientation at the liquid-vapour interface of water using an electronically coarse grained model constructed to include all long-range electronic responses within Gaussian statistics. The model, fit to the properties of the isolated monomer...

Cite
Cipcigan FS, Sokhan VP, Jones AP, et al. Hydrogen bonding and molecular orientation at the liquid-vapour interface of water. Phys Chem Chem Phys. 2015;17(14):8660-9doi: 10.1039/c4cp05506c.
Cipcigan, F. S., Sokhan, V. P., Jones, A. P., Crain, J., & Martyna, G. J. (2015). Hydrogen bonding and molecular orientation at the liquid-vapour interface of water. Physical chemistry chemical physics : PCCP, 17(14), 8660-9. https://doi.org/10.1039/c4cp05506c
Cipcigan, Flaviu S, et al. "Hydrogen bonding and molecular orientation at the liquid-vapour interface of water." Physical chemistry chemical physics : PCCP vol. 17,14 (2015): 8660-9. doi: https://doi.org/10.1039/c4cp05506c
Cipcigan FS, Sokhan VP, Jones AP, Crain J, Martyna GJ. Hydrogen bonding and molecular orientation at the liquid-vapour interface of water. Phys Chem Chem Phys. 2015 Apr 14;17(14):8660-9. doi: 10.1039/c4cp05506c. Epub 2015 Feb 26. PMID: 25715668.
Copy Download .nbib Format: NLM
Risk, Trust, and Bias: Causal Regulators of Biometric-Enabled Decision Support.

IEEE access : practical innovations, open solutions

Lai K, Oliveira HCR, Hou M, Yanushkevich SN, Shmerko VP.
PMID: 34812347
IEEE Access. 2020 Aug 11;8:148779-148792. doi: 10.1109/ACCESS.2020.3015855. eCollection 2020.

Biometrics and biometric-enabled decision support systems (DSS) have become a mandatory part of complex dynamic systems such as security checkpoints, personal health monitoring systems, autonomous robots, and epidemiological surveillance. Risk, trust, and bias (R-T-B) are emerging measures of performance...

Cite
Lai K, Oliveira HCR, Hou M, et al. Risk, Trust, and Bias: Causal Regulators of Biometric-Enabled Decision Support. IEEE Access. 2020;8:148779-148792doi: 10.1109/ACCESS.2020.3015855.
Lai, K., Oliveira, H. C. R., Hou, M., Yanushkevich, S. N., & Shmerko, V. P. (2020). Risk, Trust, and Bias: Causal Regulators of Biometric-Enabled Decision Support. IEEE access : practical innovations, open solutions, 8148779-148792. https://doi.org/10.1109/ACCESS.2020.3015855
Lai, Kenneth, et al. "Risk, Trust, and Bias: Causal Regulators of Biometric-Enabled Decision Support." IEEE access : practical innovations, open solutions vol. 8 (2020): 148779-148792. doi: https://doi.org/10.1109/ACCESS.2020.3015855
Lai K, Oliveira HCR, Hou M, Yanushkevich SN, Shmerko VP. Risk, Trust, and Bias: Causal Regulators of Biometric-Enabled Decision Support. IEEE Access. 2020 Aug 11;8:148779-148792. doi: 10.1109/ACCESS.2020.3015855. eCollection 2020. PMID: 34812347; PMCID: PMC8545314.
Copy Download .nbib Format: NLM
Hydroxyurea Induces Bone Marrow Mesenchymal Stromal Cells Senescence and Modifies Cell Functionality In Vitro.

Journal of personalized medicine

Kapor S, Vukotić M, Subotički T, Đikić D, Mitrović Ajtić O, Radojković M, Čokić VP, Santibanez JF.
PMID: 34834400
J Pers Med. 2021 Oct 20;11(11). doi: 10.3390/jpm11111048.

Hydroxyurea (HU) is an antineoplastic agent that functions as an antimetabolite compound by inhibiting the ribonucleotide reductase. HU acts mainly as a cytostatic drug that through DNA replication stress may trigger a premature senescence-like cell phenotype, though its influence...

Cite
Kapor S, Vukotić M, Subotički T, et al. Hydroxyurea Induces Bone Marrow Mesenchymal Stromal Cells Senescence and Modifies Cell Functionality In Vitro. J Pers Med. 2021;11(11)doi: 10.3390/jpm11111048.
Kapor, S., Vukotić, M., Subotički, T., Đikić, D., Mitrović Ajtić, O., Radojković, M., Čokić, V. P., & Santibanez, J. F. (2021). Hydroxyurea Induces Bone Marrow Mesenchymal Stromal Cells Senescence and Modifies Cell Functionality In Vitro. Journal of personalized medicine, 11(11), . https://doi.org/10.3390/jpm11111048
Kapor, Sunčica, et al. "Hydroxyurea Induces Bone Marrow Mesenchymal Stromal Cells Senescence and Modifies Cell Functionality In Vitro." Journal of personalized medicine vol. 11,11 (2021). doi: https://doi.org/10.3390/jpm11111048
Kapor S, Vukotić M, Subotički T, Đikić D, Mitrović Ajtić O, Radojković M, Čokić VP, Santibanez JF. Hydroxyurea Induces Bone Marrow Mesenchymal Stromal Cells Senescence and Modifies Cell Functionality In Vitro. J Pers Med. 2021 Oct 20;11(11). doi: 10.3390/jpm11111048. PMID: 34834400; PMCID: PMC8619969.
Copy Download .nbib Format: NLM
Case Report: Wound Closure Acceleration in a Patient With Toxic Epidermal Necrolysis Using a Lyophilised Amniotic Membrane.

Frontiers in bioengineering and biotechnology

Lipový B, Hladík M, Štourač P, Forostyak S.
PMID: 33937217
Front Bioeng Biotechnol. 2021 Apr 16;9:649317. doi: 10.3389/fbioe.2021.649317. eCollection 2021.

No abstract available.

Cite
Lipový B, Hladík M, Štourač P, et al. Case Report: Wound Closure Acceleration in a Patient With Toxic Epidermal Necrolysis Using a Lyophilised Amniotic Membrane. Front Bioeng Biotechnol. 2021;9:649317doi: 10.3389/fbioe.2021.649317.
Lipový, B., Hladík, M., Štourač, P., & Forostyak, S. (2021). Case Report: Wound Closure Acceleration in a Patient With Toxic Epidermal Necrolysis Using a Lyophilised Amniotic Membrane. Frontiers in bioengineering and biotechnology, 9649317. https://doi.org/10.3389/fbioe.2021.649317
Lipový, Bretislav, et al. "Case Report: Wound Closure Acceleration in a Patient With Toxic Epidermal Necrolysis Using a Lyophilised Amniotic Membrane." Frontiers in bioengineering and biotechnology vol. 9 (2021): 649317. doi: https://doi.org/10.3389/fbioe.2021.649317
Lipový B, Hladík M, Štourač P, Forostyak S. Case Report: Wound Closure Acceleration in a Patient With Toxic Epidermal Necrolysis Using a Lyophilised Amniotic Membrane. Front Bioeng Biotechnol. 2021 Apr 16;9:649317. doi: 10.3389/fbioe.2021.649317. eCollection 2021. PMID: 33937217; PMCID: PMC8085411.
Copy Download .nbib Format: NLM
Meta-arylation of calixarenes using organomercurial chemistry.

Organic & biomolecular chemistry

Slavík P, Flídrová K, Dvořáková H, Eigner V, Lhoták P.
PMID: 23863891
Org Biomol Chem. 2013 Sep 07;11(33):5528-34. doi: 10.1039/c3ob41085d.

A direct mercuration reaction combined with a subsequent Pd-catalyzed arylation was used to introduce the aryl moiety into the meta position of the calix[4]arene skeleton. The application of organomercurial intermediates thus allows the straightforward formation of meta-aryl-substituted derivatives representing...

Cite
Slavík P, Flídrová K, Dvořáková H, et al. Meta-arylation of calixarenes using organomercurial chemistry. Org Biomol Chem. 2013;11(33):5528-34doi: 10.1039/c3ob41085d.
Slavík, P., Flídrová, K., Dvořáková, H., Eigner, V., & Lhoták, P. (2013). Meta-arylation of calixarenes using organomercurial chemistry. Organic & biomolecular chemistry, 11(33), 5528-34. https://doi.org/10.1039/c3ob41085d
Slavík, Petr, et al. "Meta-arylation of calixarenes using organomercurial chemistry." Organic & biomolecular chemistry vol. 11,33 (2013): 5528-34. doi: https://doi.org/10.1039/c3ob41085d
Slavík P, Flídrová K, Dvořáková H, Eigner V, Lhoták P. Meta-arylation of calixarenes using organomercurial chemistry. Org Biomol Chem. 2013 Sep 07;11(33):5528-34. doi: 10.1039/c3ob41085d. PMID: 23863891.
Copy Download .nbib Format: NLM
Human Infections by .

Microorganisms

Hladík M, Lipovy B, Kaloudova Y, Hanslianova M, Vitkova I, Deissova T, Kempny T, Svoboda M, Kala Z, Brychta P, Borilova Linhartova P.
PMID: 34576832
Microorganisms. 2021 Sep 11;9(9). doi: 10.3390/microorganisms9091934.

No abstract available.

Cite
Hladík M, Lipovy B, Kaloudova Y, et al. Human Infections by . Microorganisms. 2021;9(9)doi: 10.3390/microorganisms9091934.
Hladík, M., Lipovy, B., Kaloudova, Y., Hanslianova, M., Vitkova, I., Deissova, T., Kempny, T., Svoboda, M., Kala, Z., Brychta, P., & Borilova Linhartova, P. (2021). Human Infections by . Microorganisms, 9(9), . https://doi.org/10.3390/microorganisms9091934
Hladík, Martin, et al. "Human Infections by ." Microorganisms vol. 9,9 (2021). doi: https://doi.org/10.3390/microorganisms9091934
Hladík M, Lipovy B, Kaloudova Y, Hanslianova M, Vitkova I, Deissova T, Kempny T, Svoboda M, Kala Z, Brychta P, Borilova Linhartova P. Human Infections by . Microorganisms. 2021 Sep 11;9(9). doi: 10.3390/microorganisms9091934. PMID: 34576832; PMCID: PMC8465362.
Copy Download .nbib Format: NLM
Serum periostin levels in asthma patients in relation to omalizumab therapy and presence of chronic rhinosinusitis with nasal polyps.

Postepy dermatologii i alergologii

Novosad J, Krčmová I, Bartoš V, Drahošová M, Vaník P, Růžičková-Kirchnerová O, Teřl M, Krejsek J.
PMID: 32489361
Postepy Dermatol Alergol. 2020 Apr;37(2):240-249. doi: 10.5114/ada.2020.94842. Epub 2020 May 06.

INTRODUCTION: The serum periostin level is a promising biomarker of type 2- high inflammation pattern of bronchial asthma. It has been proven that serum periostin levels decrease in response to systemic and inhaled corticosteroid (ICS) therapy. However, we have...

Cite
Novosad J, Krčmová I, Bartoš V, et al. Serum periostin levels in asthma patients in relation to omalizumab therapy and presence of chronic rhinosinusitis with nasal polyps. Postepy Dermatol Alergol. 2020;37(2):240-249doi: 10.5114/ada.2020.94842.
Novosad, J., Krčmová, I., Bartoš, V., Drahošová, M., Vaník, P., Růžičková-Kirchnerová, O., Teřl, M., & Krejsek, J. (2020). Serum periostin levels in asthma patients in relation to omalizumab therapy and presence of chronic rhinosinusitis with nasal polyps. Postepy dermatologii i alergologii, 37(2), 240-249. https://doi.org/10.5114/ada.2020.94842
Novosad, Jakub, et al. "Serum periostin levels in asthma patients in relation to omalizumab therapy and presence of chronic rhinosinusitis with nasal polyps." Postepy dermatologii i alergologii vol. 37,2 (2020): 240-249. doi: https://doi.org/10.5114/ada.2020.94842
Novosad J, Krčmová I, Bartoš V, Drahošová M, Vaník P, Růžičková-Kirchnerová O, Teřl M, Krejsek J. Serum periostin levels in asthma patients in relation to omalizumab therapy and presence of chronic rhinosinusitis with nasal polyps. Postepy Dermatol Alergol. 2020 Apr;37(2):240-249. doi: 10.5114/ada.2020.94842. Epub 2020 May 06. PMID: 32489361; PMCID: PMC7262810.
Copy Download .nbib Format: NLM
Effect of individual allergen sensitization on omalizumab treatment outcomes in patients with severe allergic asthma determined using data from the Czech Anti-IgE Registry.

Allergy, asthma, and clinical immunology : official journal of the Canadian Society of Allergy and Clinical Immunology

Vaník P, Novosad J, Kirchnerová O, Krčmová I, Teřl M.
PMID: 32944035
Allergy Asthma Clin Immunol. 2020 Sep 15;16:81. doi: 10.1186/s13223-020-00479-1. eCollection 2020.

BACKGROUND: Omalizumab is an efficient drug for patients with uncontrolled severe allergic asthma (SAA). However, little is known about the differences in omalizumab treatment outcomes among patients with different types of atopic sensitization. Here, we assessed the effect of...

Cite
Vaník P, Novosad J, Kirchnerová O, et al. Effect of individual allergen sensitization on omalizumab treatment outcomes in patients with severe allergic asthma determined using data from the Czech Anti-IgE Registry. Allergy Asthma Clin Immunol. 2020;16:81doi: 10.1186/s13223-020-00479-1.
Vaník, P., Novosad, J., Kirchnerová, O., Krčmová, I., Teřl, M. (2020). Effect of individual allergen sensitization on omalizumab treatment outcomes in patients with severe allergic asthma determined using data from the Czech Anti-IgE Registry. Allergy, asthma, and clinical immunology : official journal of the Canadian Society of Allergy and Clinical Immunology, 1681. https://doi.org/10.1186/s13223-020-00479-1
Vaník, Petr, et al. "Effect of individual allergen sensitization on omalizumab treatment outcomes in patients with severe allergic asthma determined using data from the Czech Anti-IgE Registry." Allergy, asthma, and clinical immunology : official journal of the Canadian Society of Allergy and Clinical Immunology vol. 16 (2020): 81. doi: https://doi.org/10.1186/s13223-020-00479-1
Vaník P, Novosad J, Kirchnerová O, Krčmová I, Teřl M. Effect of individual allergen sensitization on omalizumab treatment outcomes in patients with severe allergic asthma determined using data from the Czech Anti-IgE Registry. Allergy Asthma Clin Immunol. 2020 Sep 15;16:81. doi: 10.1186/s13223-020-00479-1. eCollection 2020. PMID: 32944035; PMCID: PMC7493349.
Copy Download .nbib Format: NLM
New Mobilities and Psychology: Why are We Still Not on the Move?.

Europe's journal of psychology

Glăveanu VP.
PMID: 33680177
Eur J Psychol. 2020 May 29;16(2):186-192. doi: 10.5964/ejop.v16i2.3117. eCollection 2020 May.

The new mobilities paradigm has been influential within the social sciences for the past two decades. And yet, psychology is undoubtably slow to incorporate mobility as a key lens through which to consider its subject area. In this editorial,...

Cite
Glăveanu VP. New Mobilities and Psychology: Why are We Still Not on the Move?. Eur J Psychol. 2020;16(2):186-192doi: 10.5964/ejop.v16i2.3117.
Glăveanu, V. P. (2020). New Mobilities and Psychology: Why are We Still Not on the Move?. Europe's journal of psychology, 16(2), 186-192. https://doi.org/10.5964/ejop.v16i2.3117
Glăveanu, Vlad P. "New Mobilities and Psychology: Why are We Still Not on the Move?." Europe's journal of psychology vol. 16,2 (2020): 186-192. doi: https://doi.org/10.5964/ejop.v16i2.3117
Glăveanu VP. New Mobilities and Psychology: Why are We Still Not on the Move?. Eur J Psychol. 2020 May 29;16(2):186-192. doi: 10.5964/ejop.v16i2.3117. eCollection 2020 May. PMID: 33680177; PMCID: PMC7913010.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 43 entries